148 results about "AMINO BASE" patented technology

A method for forming a metal oxide or nitride film on a substrate by plasma-enhanced atomic layer deposition (PEALD), includes: introducing an amino-based metal precursor in a pulse to a reaction space where a substrate is placed, using a carrier gas; and continuously introducing a reactant gas to the reaction space; applying RF power in a pulse to the reaction space wherein the pulse of the precursor and the pulse of RF power do not overlap, wherein conducted is at least either step (a) comprising passing the carrier gas through a purifier for reducing impurities before mixing the carrier gas with the precursor, or step (b) introducing the reactant gas at a flow rate such that a partial pressure of the reactant gas relative to the total gas flow provided in the reaction space is 15% or less.

The present invention relates to the field of identifying proteins and peptides, and more specifically large-scale sequencing of single peptides in a mixture of diverse peptides at the single molecule level. The present invention also relates to methods for identifying amino acids in peptides, including peptides comprising unnatural amino acids. In one embodiment, the present invention contemplates labeling the N-terminal amino acid with a first label and labeling an internal amino acid with a second label. In some embodiments, the labels are fluorescent labels. In other embodiments, the internal amino acid is Lysine. In other embodiments, amino acids in peptides are identified based on the fluorescent signature for each peptide at the single molecule level.

The subject invention provides antibodies, including polyclonal and monoclonal antibodies, that bind to E6 proteins from at least three oncogenic strains of HPV. In general, the antibodies bind to amino acids motifs that are conserved between the E6 proteins of different HPV strains, particularly HPV strains 16 and 18. The subject antibodies may be used to detect HPV E6 protein in a sample, and, accordingly, the antibodies find use in a variety of diagnostic applications, including methods of diagnosing cancer. Kits for performing the subject methods and containing the subject antibodies are also provided.

4-Amino-6-(heterocyclic)picolinic acids and their derivatives; 6-amino-2-(heterocyclic)pyrimidine-4-carboxylates and their derivatives; and methods of using the same as herbicides.

This present disclosure is related to the field of 1-(substituted-benzoyl)-5-fluoro-4-imino-3-methyl-3,4-dihydropyrimidin-2(1H)-ones and their derivatives and to the use of these compounds as fungicides. Fungicides are compounds, of natural or synthetic origin, which act to protect and / or cure plants against damage caused by agriculturally relevant fungi. Generally, no single fungicide is useful in all situations. Consequently, research is ongoing to produce fungicides that may have better performance, are easier to use, and cost less. The present disclosure relates to 1-(substituted-benzoyl)-5-fluoro-4-imino-3-methyl-3,4-dihydropyrimidin-2(1H)-one compounds and their use as fungicides. The compounds of the present disclosure may offer protection against fungi and fungi like organisms including ascomycetes, basidiomycetes, deuteromycetes, and oomycetes.

A process for producing amino-functional polysiloxanes by reacting the components A) identical or different terminally hydroxy-functional, linear or branched polysiloxanes, B) identical or different alkoxysilanes of the formulaR1xR23-xSiR3  (I)where R1 is identical or different alkyl radicals having 1 to 4 carbon atoms, R2 is identical or different alkoxy radicals having 1 to 4 carbon atoms, R3 is an organic radical having at least one nitrogen atom, x=0 to 2, and C) water, in the presence of D) one or more phosphorus-containing, Brønsted-acidic compounds, to the correspondingly obtainable polysiloxanes containing nitrogen-containing groups, and to the use thereof are provided.

Novel peptides are described which comprise an amino acid motif selected from the group consisting of “PG”, “GP”, “PI” and “IG” and having up to 10 amino acids upstream and / or downstream of the amino acid motif, wherein “P” in the motif is proline or hydroxyproline and the peptide stimulates the development, maintenance and repair of bone, cartilage and associated connective tissue. The invention further relates to pharmaceutical compositions of these peptides, as well as therapeutic and prophylactic uses of such peptides.

Disclosed herein is a photosensitive resin composition which comprises (A1) at least one compound selected from the group consisting of a silane compound represented by formula (I), a hydrolyzate thereof and a condensate of the hydrolyzate, (A2) a 1,2-quinonediazide compound, and (A3) an amino-based silane coupling agent represented by formula (II). A cured film prepared from the photosensitive resin composition has an excellent pattern development property, heat resistance and light transmittance, as well as an excellent adhesion property to a silicon nitride(SiNx) substrate, and it can be used as a protective film of an electronic component.

A method for manufacturing a highly productive key pad with rigid resin key top, wherein the key top adhesion surface 2, 6 of the key pad 1, 5 or a portion thereof is surface altered by at least one method selected from short wavelength UV irradiation treatment, corona discharge treatment, flame treatment and plasma treatment and can be adhered with reactive hardening resin 3, 7 such as urethane base resin, epoxy base resin, amino base resin, acrylic base resin, cyanoacrylate base resin and photo reactive hardening resin, thereby reducing adhesion operation time, without fear of dislocation during the adhesion.

The present invention provides an etchant composition suitable for etching metals Cu / Mo, wherein the composition comprises 1 to 25 wt % of hydrogen peroxide on the basis of the total weight of the composition; 0.1 to 15 wt % of amino acid on the basis of the total weight of the composition; 0.1 to 15 wt % of a pH stabilizer on the basis of the total weight of the composition; 0.01 to 2 wt % of fluorine-containing acid on the basis of the total weight of the composition; 0.01 to 3 wt % of an acidic pH adjuster on the basis of the total weight of the composition; and an aqueous medium. The present invention also provides a process for etching metals Cu / Mo with the etchant composition of the present invention.

The invention relates to preservative systems which are particularly suitable in cosmetic and dermatological preparations. The preservative system which comprises a cationic surfactant, derived from the condensation of fatty acids and esterified dibasic amino acids, having the formula (I) where: X− is Br−, Cl−, or HSO4 R1: is a straight alkyl chain from an acid or saturated fatty hydroxy acid from 8 to 14 atoms of carbon bonded to the α-amino acid group through amidic bond. R2: is a straight or branched alkyl chain from 1 to 18 carbon atoms or aromatic. R3: is: (II) where n can be from 0 to 4, is combined with at least one other ionic or non-ionic preservative agent, whereby the combination displays a synergetic activity. A preservative system, wherein the cationic surfactant preservative derived from the condensation of fatty acids and esterified dibasic amino acid is LAE is particularly preferred. The other ionic or non ionic preservative agent is preferably at least one component selected from the group consisting of 2-bromo-2-nitro-1,3-propanediol (bronopol), parbens, imidazolidinyl urea, phenoxyethanol, DMDM hydantoin, 2-methyl-5-chloro-3,4-isothiazolinone / 2-methyl-3,4-isothiazolinone and quaternium-15.

The disclosure provide a sulfur-free and halogen-free synergistic additive concentrate for a fuel injected engine. The additive concentrate includes (a) an alkoxylated quaternary ammonium salt of the formula (R1)nN[(R2O)xH]m, wherein R1 contains from 1 to 25 carbon atoms, R2 contains from 1 to 4 carbon atoms, n and m are each integers from 1 to 3, provided n+m=4, and x is an integer of from 1 to 5; and (b) a material containing a hydrogen-bonding group other than an alkyl hydroxyl group selected from the group consisting of a hydrocarbyl acid; hydrocarbyl polyacid; hydrocarbyl substituted hydroxybenzene; hydrocarbyl substituted succinic diamide, acid / amide, diacid, diester, ester / acid, amide / ester, imide; aminotriazole, and mixtures thereof, wherein the hydrocarbyl substituent has a number average molecular weight of from about 100 to about 1500, and wherein a weight ratio of (a) to (b) in the additive ranges from about 1:5 to about 1:1.

The invention discloses a cationic polyamino acid group carrier material and a preparation method thereof. according to the preparation method, a random copolymer of aspartic acid benzyl ester and histidine is prepared through ring opening polymerization of N-carboxyl-alpha-amino anhydride, and an aminolysis reaction is carried out on an aspartic acid side chain, so as to synthesize the cationic polyamino acid group carrier material. A gel permeation chromatography result shows that the molecular weight of the polymer can be effectively controlled through controlling inventory of an initiator; under different aminolysis proportions, the polymers are different in solubility and transform from hydrophobic property to hydrophilic property; in-vitro gene transfection experiment result shows that polymers P (HIS-(i) co( / i)-ASP (DET)) with aminolysis proportion ranging from 10% to 95% have gene transfection efficiency, and a polymer with the maximum transfection efficiency can be screened out through changing the mass ratio of material to gene; the polymers P (HIS-(i) co( / i)-ASP (DET), compared to a homopolymerized aspartic acid polymer, are obviously low in cytotoxicity; and the obtained polymer is a gene carrier material which is low in toxicity, high in efficiency, excellent in biocompatibility and biodegradable.

The present invention relates to methods for identifying amino acids in peptides. In one embodiment, the present invention contemplates labeling the N-terminal amino acid with a first label and labeling an internal amino acid with a second label. In some embodiments, the labels are fluorescent labels. In other embodiments, the internal amino acid is lysine. In other embodiments, amino acids in peptides are identified based on the fluorescent signature for each peptide at the single molecule level.

A chemical treatment liquid for steel material coating primer comprising a zirconium fluorine complex amounting to 50 to 500 ppm by mass in terms of Zr, free fluorine amounting to 5 to 50 ppm by mass and a polyethyleneimine of 300 to 10,000 weight average molecular weight wherein the molar ratios of primary amino and tertiary amino based on the total quantity of amino are 30% or more and 15% or more, respectively, amounting to 5 to 30% by mass based on Zr so as to exhibit a pH value of 3 to 5. Further, there is provided a relevant method of chemical treatment. In the instance of steel material coating, especially electrodeposition coating, there can be realized excellent coating film adhesion, post-coating corrosion resistance and coating adhering-around property.

Novel Amino Acid Derivatives and Pharmaceutical Uses Thereof Provided are novel compounds of Formula I:wherein ‘X’ represents an amino acid group, ‘n’ is an integer between 1 and 4, ‘R1’ represents benzyl, t-butyl or 9-fluorenylmethyl and ‘R2’ represents a tetramethylmercaptoimidazole derivative or —S+R3R4, wherein R3 and R4 each independently represent lower alkyl, or a pharmaceutically and / or veterinarily acceptable derivative thereof. Further provided are pharmaceutical formulations of the compounds and the use thereof in the preparation of a medicament for inhibiting diseases in which transglutaminase has been implicated. Advantageously, the medicament is for treating fibrosis, scarring and / or cancer. Additionally provided are methods, of inhibiting autoimmune diseases such as coeliac disease, neurodegeneration and chronic inflammatory diseases (e.g. of the joints including rheumatoid arthritis and osteoarthritis in a subject) and a method for preventing or treating rejection of a transplanted organ.